Natera, Inc. (NTRA)
328.77
+2.63
(+0.81%)
USD |
NASDAQ |
Sep 11, 12:27
Natera Cash from Operations (Annual) : 215.30M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 215.30M |
| December 31, 2024 | 135.66M |
| December 31, 2023 | -246.96M |
| December 31, 2022 | -431.50M |
| December 31, 2021 | -335.24M |
| December 31, 2020 | -182.51M |
| December 31, 2019 | -63.44M |
| Date | Value |
|---|---|
| December 31, 2018 | -70.58M |
| December 31, 2017 | -97.82M |
| December 31, 2016 | -74.05M |
| December 31, 2015 | -37.56M |
| December 31, 2014 | 10.49M |
| December 31, 2013 | -24.13M |
| December 31, 2012 | -14.90M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Guardant Health, Inc. | -184.76M |
| CareDx, Inc. | 42.03M |
| Myriad Genetics, Inc. | 1.80M |
| BioRestorative Therapies, Inc. | -10.79M |
| Exagen, Inc. | -13.62M |